abstract |
The present invention relates to methods of treating, reducing, minimizing or preventing HIV-1/AIDS by administering CD24 to a subject in need thereof. Also provided is the use of the CD24 protein in the manufacture of a medicament for the treatment of HIV-1/AIDS. In addition, pharmaceutical compositions comprising a pharmaceutically acceptable amount of CD24 protein are provided. |